Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma
Oral squamous cell carcinoma (OSCC) is a heterogeneous malignancy originating from the oral mucosal epithelium. Detecting novel biomarkers can offer crucial information on disease aggressiveness and expected clinical outcomes for individual patients. SEC61G, an aberrantly expressed gene in various c...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/10/2718 |
_version_ | 1827721561574998016 |
---|---|
author | Shi-Long Zhang Lei Chen Lin-Lin Bu Zi-Li Yu Si-Rui Ma |
author_facet | Shi-Long Zhang Lei Chen Lin-Lin Bu Zi-Li Yu Si-Rui Ma |
author_sort | Shi-Long Zhang |
collection | DOAJ |
description | Oral squamous cell carcinoma (OSCC) is a heterogeneous malignancy originating from the oral mucosal epithelium. Detecting novel biomarkers can offer crucial information on disease aggressiveness and expected clinical outcomes for individual patients. SEC61G, an aberrantly expressed gene in various cancers, has been associated with negative clinical outcomes. However, its expression and clinical significance in OSCC is still unclear. In the present study, we investigated the SEC61G expression level in OSCC using bioinformatic and immunohistochemical analyses. Additionally, our findings revealed a significant correlation between SEC61G expression and clinicopathological characteristics, as well as a worse prognosis in OSCC patients. Notably, flow cytometry analysis on patient samples revealed that SEC61G expression was also linked to decreased immune infiltration in OSCC patients. In conclusion, our study provides evidence supporting SEC61G’s role as a potential diagnostic, prognostic, and therapeutic marker in OSCC. |
first_indexed | 2024-03-10T21:25:07Z |
format | Article |
id | doaj.art-0ad9995ea3b84cb6bcc86d54d5cf5cba |
institution | Directory Open Access Journal |
issn | 2227-9059 |
language | English |
last_indexed | 2024-03-10T21:25:07Z |
publishDate | 2023-10-01 |
publisher | MDPI AG |
record_format | Article |
series | Biomedicines |
spelling | doaj.art-0ad9995ea3b84cb6bcc86d54d5cf5cba2023-11-19T15:46:06ZengMDPI AGBiomedicines2227-90592023-10-011110271810.3390/biomedicines11102718Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell CarcinomaShi-Long Zhang0Lei Chen1Lin-Lin Bu2Zi-Li Yu3Si-Rui Ma4State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, ChinaState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, ChinaState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, ChinaState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, ChinaState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, ChinaOral squamous cell carcinoma (OSCC) is a heterogeneous malignancy originating from the oral mucosal epithelium. Detecting novel biomarkers can offer crucial information on disease aggressiveness and expected clinical outcomes for individual patients. SEC61G, an aberrantly expressed gene in various cancers, has been associated with negative clinical outcomes. However, its expression and clinical significance in OSCC is still unclear. In the present study, we investigated the SEC61G expression level in OSCC using bioinformatic and immunohistochemical analyses. Additionally, our findings revealed a significant correlation between SEC61G expression and clinicopathological characteristics, as well as a worse prognosis in OSCC patients. Notably, flow cytometry analysis on patient samples revealed that SEC61G expression was also linked to decreased immune infiltration in OSCC patients. In conclusion, our study provides evidence supporting SEC61G’s role as a potential diagnostic, prognostic, and therapeutic marker in OSCC.https://www.mdpi.com/2227-9059/11/10/2718oral squamous cell carcinomaSEC61Gprognosisimmune infiltration |
spellingShingle | Shi-Long Zhang Lei Chen Lin-Lin Bu Zi-Li Yu Si-Rui Ma Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma Biomedicines oral squamous cell carcinoma SEC61G prognosis immune infiltration |
title | Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma |
title_full | Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma |
title_fullStr | Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma |
title_full_unstemmed | Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma |
title_short | Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma |
title_sort | identification of sec61g as a diagnostic and prognostic biomarker in oral squamous cell carcinoma |
topic | oral squamous cell carcinoma SEC61G prognosis immune infiltration |
url | https://www.mdpi.com/2227-9059/11/10/2718 |
work_keys_str_mv | AT shilongzhang identificationofsec61gasadiagnosticandprognosticbiomarkerinoralsquamouscellcarcinoma AT leichen identificationofsec61gasadiagnosticandprognosticbiomarkerinoralsquamouscellcarcinoma AT linlinbu identificationofsec61gasadiagnosticandprognosticbiomarkerinoralsquamouscellcarcinoma AT ziliyu identificationofsec61gasadiagnosticandprognosticbiomarkerinoralsquamouscellcarcinoma AT siruima identificationofsec61gasadiagnosticandprognosticbiomarkerinoralsquamouscellcarcinoma |